tiprankstipranks
Trending News
More News >
Emergent Biosolutions (EBS)
NYSE:EBS

Emergent Biosolutions (EBS) Revenue

Compare
1,276 Followers

Emergent Biosolutions Revenue

Emergent Biosolutions had a revenue of 189.30M in the quarter ending Dec 31, 2024, with -35.57%. This bring the company's revenue in the last twelve months to 1.04B, Increased -7.76%. In the fiscal year ending Dec 31, 2024, Emergent Biosolutions had annual revenue of 1.01B with -3.40% growth.
Revenue (ttm)
1.04B
Revenue Growth
-0.62%
P/S Ratio
0.23
Revenue/Employee
$1,126,222
Employees
900
Market Cap
$231.48M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20241.01B-35.70M-3.40%
Dec 31, 20231.05B-71.60M-6.39%
Dec 31, 20221.12B-671.80M-37.47%
Dec 31, 20211.79B237.30M+15.26%
Dec 31, 20201.56B449.40M+40.63%
Dec 31, 20191.11B323.60M+41.36%
Dec 31, 2018782.40M221.53M+39.50%
Dec 31, 2017560.87M72.09M+14.75%
Dec 31, 2016488.78M-34.01M-6.50%
Dec 31, 2015522.79M72.65M+16.14%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis